Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE)

Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy

(2022) Jingshi Chen et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease

(2021) Jessica A. Starr et al.   ANNALS OF PHARMACOTHERAPY

Executive Summary

(2021) Scott M. Stevens et al.   CHEST

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

(2020) John W. Stanifer et al.   CIRCULATION

The REDCap consortium: Building an international community of software platform partners

(2019) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease

(2018) Joseph H. Schafer et al.   ANNALS OF PHARMACOTHERAPY

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study

(2018) Frederikus A. Klok et al.   BRITISH JOURNAL OF HAEMATOLOGY

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

(2017) Thomas A. Mavrakanas et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial

(2015) Xianchen Liu et al.   Journal of the American Heart Association

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

(2013) T. van der Hulle et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms

(2009) Keattiyoat Wattanakit et al.   CURRENT OPINION IN PULMONARY MEDICINE

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Chronic Kidney Disease Increases Risk for Venous Thromboembolism

(2007) K. Wattanakit et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY